Exploring Novel Molecular Targets for the Treatment of High-Grade Astrocytomas Using Peptide Therapeutics: An Overview
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploring Novel Molecular Targets for the Treatment of High-Grade Astrocytomas Using Peptide Therapeutics: An Overview
Authors
Keywords
-
Journal
Cells
Volume 9, Issue 2, Pages 490
Publisher
MDPI AG
Online
2020-02-25
DOI
10.3390/cells9020490
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Astrocytoma progression scoring system based on the WHO 2016 criteria
- (2019) Zhen-Hang Li et al. Scientific Reports
- Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization
- (2019) Vadim Le Joncour et al. EMBO Molecular Medicine
- Advances in Targeting the Epidermal Growth Factor Receptor Pathway by Synthetic Products and Its Regulation by Epigenetic Modulators As a Therapy for Glioblastoma
- (2019) Nadeem Abbas et al. Cells
- Peptides as cancer vaccines
- (2019) Marta Calvo Tardón et al. CURRENT OPINION IN PHARMACOLOGY
- Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics
- (2019) Silantyev et al. Cells
- Vasculogenic Mimicry: Become an Endothelial Cell “But Not So Much”
- (2019) Mónica Fernández-Cortés et al. Frontiers in Oncology
- Fibrin As a Target for Glioblastoma Detection and Treatment
- (2019) Lynn M Knowles et al. BLOOD
- Genetic and Lineage Classification of Glioma-Initiating Cells Identifies a Clinically Relevant Glioblastoma Model
- (2019) Norihiko Saito et al. Cancers
- Seek & Destroy , use of targeting peptides for cancer detection and drug delivery
- (2018) Vadim Le Joncour et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Phase I and biomarker study of plerixafor and bevacizumab in recurrent high-grade glioma
- (2018) Eudocia Q Lee et al. CLINICAL CANCER RESEARCH
- Glioma targeting peptide modified apoferritin nanocage
- (2018) Meifang Zhai et al. DRUG DELIVERY
- Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
- (2018) Frederick F. Lang et al. JOURNAL OF CLINICAL ONCOLOGY
- Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies
- (2018) Zhenyi An et al. ONCOGENE
- Investigating the role of Hedgehog/GLI1 signaling in glioblastoma cell response to temozolomide
- (2018) Jilian R. Melamed et al. Oncotarget
- Current therapeutic approaches to diffuse grade II and III gliomas
- (2018) Alberto Picca et al. Therapeutic Advances in Neurological Disorders
- Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide
- (2018) Israel López-Valero et al. BIOCHEMICAL PHARMACOLOGY
- Primary brain tumours in adults
- (2018) Sarah Lapointe et al. LANCET
- Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review
- (2018) Margriet IJzerman-Korevaar et al. JOURNAL OF NEURO-ONCOLOGY
- Expression of neuropilin-1 is linked to glioma associated microglia and macrophages and correlates with unfavorable prognosis in high grade gliomas
- (2018) Michael D. Caponegro et al. Oncotarget
- Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer
- (2018) Franziska Eckert et al. Frontiers in Immunology
- EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment
- (2017) Stefanie Keller et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- Vaccine-based immunotherapeutic approaches to gliomas and beyond
- (2017) Michael Weller et al. Nature Reviews Neurology
- Personalized peptide vaccines and their relation to other therapies in urological cancer
- (2017) Takahiro Kimura et al. Nature Reviews Urology
- Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data
- (2017) Jann N Sarkaria et al. NEURO-ONCOLOGY
- The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision
- (2017) Takashi KOMORI NEUROLOGIA MEDICO-CHIRURGICA
- Cell-Penetrating Peptides: From Basic Research to Clinics
- (2017) Giulia Guidotti et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death
- (2017) Yu Wang et al. Oncotarget
- Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update
- (2017) Laure Malric et al. Oncotarget
- Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications
- (2017) Berthony Deslouches et al. Oncotarget
- Antimicrobial Peptides As Biologic and Immunotherapeutic Agents against Cancer: A Comprehensive Overview
- (2017) Raheleh Roudi et al. Frontiers in Immunology
- Neuropilin-1 modulates TGFβ signaling to drive glioblastoma growth and recurrence after anti-angiogenic therapy
- (2017) Sam C. Kwiatkowski et al. PLoS One
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment
- (2016) Ting Kang et al. BIOMATERIALS
- RGD peptide conjugation results in enhanced antitumor activity of PD0325901 against glioblastoma by both tumor-targeting delivery and combination therapy
- (2016) Jianjun Hou et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model
- (2016) Laura Mercurio et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- AKT/GSK3β Signaling in Glioblastoma
- (2016) Ewelina Majewska et al. NEUROCHEMICAL RESEARCH
- Integrins in glioblastoma: Still an attractive target?
- (2016) Mayra Paolillo et al. PHARMACOLOGICAL RESEARCH
- PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
- (2016) Xiaoman Li et al. Oncotarget
- Clonal Variation in Drug and Radiation Response among Glioma-Initiating Cells Is Linked to Proneural-Mesenchymal Transition
- (2016) Anna Segerman et al. Cell Reports
- Cognitive Rehabilitation in Patients with Gliomas and Other Brain Tumors: State of the Art
- (2016) E. Bergo et al. Biomed Research International
- Multi-targeting Peptide-Functionalized Nanoparticles Recognized Vasculogenic Mimicry, Tumor Neovasculature, and Glioma Cells for Enhanced Anti-glioma Therapy
- (2015) Xingye Feng et al. ACS Applied Materials & Interfaces
- Mammary-Derived Growth Inhibitor Targeting Peptide-Modified PEG–PLA Nanoparticles for Enhanced Targeted Glioblastoma Therapy
- (2015) Xingye Feng et al. BIOCONJUGATE CHEMISTRY
- Peptide therapeutics: current status and future directions
- (2015) Keld Fosgerau et al. DRUG DISCOVERY TODAY
- Cancer stem cells in glioblastoma
- (2015) Justin D. Lathia et al. GENES & DEVELOPMENT
- Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation
- (2015) Shuli Xia et al. NEURO-ONCOLOGY
- Role of tenascins in the ECM of gliomas
- (2015) Nicole Brösicke et al. Cell Adhesion & Migration
- iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas
- (2014) Ting Kang et al. BIOMATERIALS
- Peptide-based cancer therapy: Opportunity and challenge
- (2014) Dongdong Wu et al. CANCER LETTERS
- Bioinformatics analysis reveals disturbance mechanism of MAPK signaling pathway and cell cycle in Glioblastoma multiforme
- (2014) Wusheng Li et al. GENE
- The role of CXCR4 in highly malignant human gliomas biology: Current knowledge and future directions
- (2014) Filippo Gagliardi et al. GLIA
- Peptide vaccines for the treatment of glioblastoma
- (2014) Adam M. Swartz et al. JOURNAL OF NEURO-ONCOLOGY
- Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
- (2014) Roger Stupp et al. LANCET ONCOLOGY
- Novel Target for Peptide-Based Imaging and Treatment of Brain Tumors
- (2014) M. Hyvonen et al. MOLECULAR CANCER THERAPEUTICS
- The Impact of Inpatient Rehabilitation on Function and Survival of Newly Diagnosed Patients With Glioblastoma
- (2014) Pamela S. Roberts et al. PM&R
- Tenascin-C is expressed by human glioma in vivo and shows a strong association with tumor blood vessels
- (2013) Nicole Brösicke et al. CELL AND TISSUE RESEARCH
- Phase I Study of GRN1005 in Recurrent Malignant Glioma
- (2013) J. Drappatz et al. CLINICAL CANCER RESEARCH
- Approaches for enhancing oral bioavailability of peptides and proteins
- (2013) Jwala Renukuntla et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The role of the CXCR4 cell surface chemokine receptor in glioma biology
- (2013) Moneeb Ehtesham et al. JOURNAL OF NEURO-ONCOLOGY
- Preclinical Development of a Novel Class of CXCR4 Antagonist Impairing Solid Tumors Growth and Metastases
- (2013) Luigi Portella et al. PLoS One
- Evolutionary etiology of high-grade astrocytomas
- (2013) Y. Song et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells
- (2013) Y. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity
- (2013) Monica Gatti et al. TOXICOLOGY
- Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance
- (2012) T. E. Taylor et al. CURRENT CANCER DRUG TARGETS
- A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target
- (2011) Alexander Schulte et al. GLIA
- A New Phage-Display Tumor-Homing Peptide Fused to Antiangiogenic Peptide Generates a Novel Bioactive Molecule with Antimelanoma Activity
- (2011) A. L. Matsuo et al. MOLECULAR CANCER RESEARCH
- A Phase 1 Trial of ABT-510 Concurrent With Standard Chemoradiation for Patients With Newly Diagnosed Glioblastoma
- (2010) Louis B. Nabors et al. ARCHIVES OF NEUROLOGY
- Induction of in vivo synthetic lethal RNAi responses to treat glioblastoma
- (2010) Hiroyuki Michiue et al. CANCER BIOLOGY & THERAPY
- Mammary-derived growth inhibitor (MDGI) interacts with integrin α-subunits and suppresses integrin activity and invasion
- (2010) J Nevo et al. ONCOGENE
- Efficient siRNA delivery into primary cells by a peptide transduction domain–dsRNA binding domain fusion protein
- (2009) Akiko Eguchi et al. NATURE BIOTECHNOLOGY
- Discovering and improving novel peptide therapeutics
- (2008) D MCGREGOR CURRENT OPINION IN PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started